RASA, a recombinant single-chain variable fragment (scFv) antibody directed against the human sperm surface: Implications for novel contraceptives

Human Reproduction

Volumn 16, Issue 9, 2001, Pages 1854-1860

  Norton, E J ^a   Diekman, A B ^a   Westbrook, V A ^a   Flickinger, C J ^a   Herr, J C ^a,b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b Board of Directors of Contra Vac Inc   (United States)

Author keywords

Agglutination; Antibody engineering; Contraception; Recombinant antibody; Single chain Fv

Indexed keywords

CARBOHYDRATE; CD52 ANTIGEN; COMPLEMENTARY DNA; CONTRACEPTIVE AGENT; EPITOPE; HUMAN SPERM AGGLUTINATION ANTIGEN 1; IMMUNOGLOBULIN KAPPA CHAIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY S19; MONOMER; POLYMER; RECOMBINANT ANTIBODY; RECOMBINANT SPERM ANTIBODY; SPERM ANTIBODY; SPERM ANTIGEN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ARTICLE; BIOENGINEERING; CELL AGGREGATION; CELL LABELING; CELL SURFACE; CLONING VECTOR; CONTROLLED STUDY; DNA VECTOR; ESCHERICHIA COLI; GENETIC CODE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN VARIABLE REGION; MALE; NONHUMAN; PROTEIN EXPRESSION; SPERMATOZOON; SPERMATOZOON TAIL; TISSUE SPECIFICITY; WESTERN BLOTTING;

ESCHERICHIA COLI; RASA;

EID: 0034803883     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/16.9.1854     Document Type: Article

References (45)

1. Monoclonal antibodies to human trophoblast and sperm antigens: Report of two WHO-sponsored workshops, June, 30, 1986-Toronto, Canada
2. Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment
3. L domains dictates precisely the transition between diabodies and triabodies
4. Evidence that an Arg-Gly-Asp adhesion sequence plays a role in mammalian fertilization
5. Hybridoma fusion cell lines contain an aberrant kappa transcript
6. Contraceptive effect of sperm-agglutinating monoclonal antibodies in rabbits
7. Ras and p53 intracellular targeting with recombinant single-chain Fv (scFv) fragments: A novel approach for cancer therapy?
8. Design and production of novel tetravalent bispecific antibodies
9. Monoclonal antibodies for reproductive health: Part I. Preventing sexual transmission of disease and pregnancy with topically applied antibodies
10. Multimerization behaviour of single chain Fv variants for the tumour-binding antibody B72.3
11. Sperm antigens: Where are the private specificities?
12. Biochemical characterization of sperm agglutination antigen-1, a human sperm specific antigen implicated in gamete interactions
13. N-linked glycan of a sperm CD52 glycoform associated with human infertility
14. Colony assays for antibody fragments expressed in bacteria
15. 2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections
16. Construction of the single-chain Fv from 196-14 antibody toward ovarian cancer-associated antigen CA125
17. Antibodies come back from the brink
18. Recombinant antibody fragments
19. Recombinant antibody constructs in cancer therapy
20. High avidity scFv multimers; Diabodies and triabodies
21. Establishment and characterization of a human hybridoma secreting monoclonal antibody with high titers of sperm immobilizing and agglutination activities against human seminal plasma
22. Domain interactions in antibody Fv and scFv fragments: Effects on unfolding kinetics and equilibria
23. Rapid PCR-cloning of full-length mouse immunoglobulin variable regions
24. High level production of soluble single chain antibodies in small-scale Escherichia coli cultures
25. CD52 is the 'major maturation-associated' sperm membrane antigen
26. Complement recruitment using bispecific diabodies
27. Recombinant anti-sialidase single-chain variable fragment antibody. Characterization, formation of dimer and higher-molecular mass multimers and the solution of the crystal structure of the single-chain variable fragment/sialidase complex
28. Synthesis of pesticide-specific single-chain Fv utilizing the recombinant phage antibody system (RPAS, Pharmacia). A detailed protocol
29. Will immunogenicity limit the use, efficacy, and future development of therapeutic monoclonal antibodies?
30. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
31. Molecular cloning of the human and monkey sperm surface protein PH-20
32. Evaluation of sperm-zona pellucida tight binding by presence of monoclonal antibodies to sperm antigens
33. Isolation and characterization of an anti-CD16 single-chain Fv fragment and construction of an anti-HER2/neu/anti-CD16 bispecific scFv that triggers CD16-dependent tumor cytolysis
34. An efficient route to human bispecific IgG
35. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction
36. Effects of multiple applications of benzalkonium chloride and nonoxynol-9 on the vaginal epithelium in the pigtailed macaque (macaca nemestrina)
37. Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of mAb CC49 in colon carcinoma xenografts
38. Techniques for detection of iso- and auto-antibodies to human spermatozoa
39. High cytoplasmic expression in E. coli, purification, and in-vitro refolding of a single chain Fv antibody fragment against the hepatitis B surface antigen
40. Male-specific modification of human CD52
41. A better cell line for making hybridomas secreting specific antibodies
42. In-vivo transduction: Delivery of a biologically active protein in the mouse
43. Widely used spermicide may increase, not decrease, risk of HIV transmission
44. A procedure for the quantitative isolation of brain gangliosides
45. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications